Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|
Net Debt | ($1,045.6M) | ($740.3M) | ($1,487.9M) | ($970.6M) | ($4,371.0M) | ($8,935.0M) | ($8,654.0M) | ($7,361.0M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Moderna, Inc.'s last 12-month Net Debt is ($340.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Moderna, Inc.'s Net Debt growth was (94.4%). The average annual Net Debt growth rates for Moderna, Inc. have been (64.3%) over the past three years, (19.8%) over the past five years.
Over the last year, Moderna, Inc.'s Net Debt growth was (94.4%), which is lower than industry growth of (0.1%). It indicates that Moderna, Inc.'s Net Debt growth is Good.